Enzyme / Abzyme Prodrug Activation Systems: Potential Use in Clinical Oncology
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2113-2130
Author(s):
Yoshisuke Nishi
Tumor Escape from Immune Response: Mechanisms and Targets of Activity
Journal:
Current Drug Targets
Volume:
4
Page:
525-536
Author(s):
Dmitry Gabrilovich and Vladimir Pisarev
Thirty Years of Polyamine-Related Approaches to Cancer Therapy. Retrospect and Prospect. Part 1. Selective Enzyme Inhibitors
Journal:
Current Drug Targets
Volume:
4
Page:
537-564
Author(s):
Nikolaus Seiler
Role of Cytokines in Neurological Disorders
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
1931-1937
Author(s):
Johan A. Aarli
Molecular Mimicry in Autoimmune Neurological Disease after Viral Infection
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
1939-1943
Author(s):
Bart O. Roep
The Clinical Spectrum, Diagnosis, Pathogenesis and Treatment of Hashimotos Encephalopathy (Recurrent Acute Disseminated Encephalomyelitis)
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
1945-1953
Author(s):
Abhijit Chaudhuri and Peter O. Behan
Preface [Hot topic: Implications of COX-2 Inhibition in the Gastrointestinal Tract (Executive Editor : Angel Lanas)]
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
ii-ii
Author(s):
Angel Lanas
Cyclooxygenase-2 Biology
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2177-2190
Author(s):
Joan Claria
Dual COX Inhibition and Upper Gastrointestinal Damage
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2191-2195
Author(s):
M. M. Skelly and C. J. Hawkey
Gastroduodenal Safety of Cyclooxygenase-2 Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2197-2206
Author(s):
James M. Scheiman